Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Present

Posted Jun 15 by Two Blokes

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-t

Source: Two Blokes Trading

Investigational combination of first-in-class bispecifics TALVEY\u00ae and TECVAYLI\u00ae shows deep and durable responses in he

Posted Jun 15 by Two Blokes

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate

Source: Two Blokes Trading

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expre

Posted Jun 15 by Two Blokes

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt P

Source: Two Blokes Trading

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or R

Posted Jun 15 by Two Blokes

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new results from the Phase 1b/

Source: Two Blokes Trading

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or R

Posted Jun 15 by Two Blokes

Media Release COPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE \u00ae NHL-2 trial show investigation

Source: Two Blokes Trading

3 Reasons Why This Beaten-Down Growth Stock Could Trounce the S&P 500 in the Second Half of 2025

Posted Jun 15 by Two Blokes

Apple (AAPL -1.62%) is in the bottom 10% of S&P 500 stocks when measuring year-to-date performance. The stock

Source: Two Blokes Trading

Warren Buffett Has $90 Billion Invested in These 9 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.

Posted Jun 15 by Two Blokes

Warren Buffett readily admits that he doesn't understand artificial intelligence (AI). He has also said that h

Source: Two Blokes Trading

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys\u2122 gene therapy for Duchenne muscular d

Posted Jun 15 by Two Blokes

Basel, 15 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new dosing restrictions, effective im

Source: Two Blokes Trading

Statistically and Historically Speaking, 2 of Wall Street's Highest-Flying Stocks Are in Epic Bubbles That I Fully Expect to Bur

Posted Jun 15 by Two Blokes

For well over a century, Wall Street has been a stomping ground for wealth creation. Although getting from Poi

Source: Two Blokes Trading

Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Present

Posted Jun 15 by Two Blokes

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Positive Late-Breaking Data for Incyte's First-in-Class mutCALR-t

Source: Two Blokes Trading

Investigational combination of first-in-class bispecifics TALVEY\u00ae and TECVAYLI\u00ae shows deep and durable responses in he

Posted Jun 15 by Two Blokes

Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate

Source: Two Blokes Trading

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expre

Posted Jun 15 by Two Blokes

VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt P

Source: Two Blokes Trading